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Abstract
Background: Violence against women is a global public health problem with negative effects on physical, mental,
and reproductive health. The World Health Organization (WHO) has identified intimate partner violence (IPV) and
sexual violence (SV) as major targets for prevention and amelioration and recently developed clinical and policy
guidelines to assist healthcare providers. This project was undertaken to determine the 2013 baseline national policies
and clinical guidelines on IPV and SV within the Latin American and Caribbean (LAC) region to identify strengths and
gaps requiring action.
Methods: Each Pan American Health Organization/World Health Organization Regional Office for the Americas
(PAHO/WHO) country focal point was contacted to request their current national policy and clinical guidelines
(protocol) on IPV/SV. We augmented this by searching the internet and the United Nations Women website. Each
country’s policy and clinical guideline (where available) was reviewed and entered into a scoring matrix based on
WHO Clinical and Policy Guidelines. A total score for each heading and subheading was developed by adding positive
responses to identify LAC regional strengths and gaps.
Results: We obtained 15 national policies and 12 national clinical guidelines (protocols) from a total of 18 countries
(“response” rate 66.7 %). National policies were comprehensive in terms of physical, emotional, and sexual violence and
recommended good intersectoral collaboration. The greatest gap was in the training of health-care providers. National
Guidelines for women-centered care for IPV/SV survivors were strong in the vital areas of privacy, confidentiality, danger
assessment, safety planning, and supportive reactions to disclosure. The largest gaps noted were again in training
healthcare professionals and strengthening monitoring and evaluation of services.
Conclusions: Baseline measurement of policy and clinical guidelines for IPV/SV in LAC PAHO/WHO member countries at
the time of issuing the 2013 WHO Clinical and Policy Guidelines reveals some important strengths, but also serious gaps
that need to be addressed. The most pressing needs are for concerted training initiatives for healthcare providers
and strengthening multisectoral monitoring and evaluation of services. A future evaluation of national policies,
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Background
Violence against women is a global public health problem
and a violation of human rights, which has substantial
negative effects on physical, mental, and reproductive
health, as well as detrimental social and economic
impacts [1]. While there are several types of violence,
the World Health Organization (WHO) has identified
intimate partner violence (IPV) and sexual violence (SV)
as major targets for prevention and amelioration [2]. A
common theme for both IPV and SV is the use of violence
as an expression of control, power and domination. Sev-
eral definitions of these terms exist, but common ones for
IPV include physical, sexual or psychological harm by a
current or former partner or spouse, which can occur
among heterosexual or same-sex partners and does not
require sexual intimacy [3]. Sexual violence is any act
perpetrated against someone’s will, including a com-
pleted non-consensual sex act (rape), an attempted
non-consensual sex act, abusive sexual contact (e.g. un-
wanted touching) or noncontact sexual abuse (e.g. exhib-
itionism, threats of sexual violence, sexual harassment) [4].
The prevalence of IPV and SV varies internationally,
partly due to different definitions and approaches to meas-
urement. However, a WHO multicountry study (24,000
women) on domestic violence against women in 10 coun-
tries, using comparable data, found the highest lifetime
prevalence (61 %) of physical IPV in rural Peru [5]. Other
studies also report high rates of IPV in other Latin
American [6, 7] and Caribbean countries [8]. The Pan
American Health Organization/World Health Organization
Regional Office for the Americas (PAHO/WHO) provides
technical cooperation and mobilizes partnerships to im-
prove health and quality of life in the countries of the
Americas, including in Latin America and the Caribbean
(LAC) [9].
In response to requests from Member States and as part
of its efforts to prevent and ameliorate IPV and SV, WHO
developed clinical and policy guidelines to assist healthcare
providers, who are likely to be the first professional contact
for survivors. To develop these clinical and policy guide-
lines an expert panel was assembled for a Guideline De-
velopment Group which included academics, clinicians/
service providers, policy makers, and women’s health and
rights advocates from across the globe, including low- and
middle-income countries. A literature review was under-
taken and scientific evidence for recommendations was
synthesized using the Grading of Recommendations As-
sessment, Development and Evidence (GRADE) method-
ology [10]. Recommendations were agreed upon by the
Guideline Development Group and were then reviewed by
peer reviewers and a wide range of stakeholders before the
final report was released in July 2013 [11].
A useful first step in implementing the new WHO
Clinical and Policy Guidelines is to determine the
existing (baseline) national policies and clinical guide-
lines for IPV and SV to identify strengths and gaps. This
project, supported by PAHO/WHO, was undertaken to
determine the 2013 baseline national policies and clin-
ical guidelines on IPV and SV within the LAC region.
Methods
Four sources were used to obtain the maximum number
of national policies and clinical guidelines in each LAC
country member of PAHO in which the primary lan-
guage was Spanish, English or Portuguese. Each PAHO/
WHO country focal point was contacted in July 2013 by
the PAHO/WHO Regional Advisor on Family Violence
(AG) to inform them about this project, to introduce the
trilingual study coordinator (RA), and to ask them to
send their current national policy and clinical guidelines
(protocol) on IPV/SV. This was followed up by the study
coordinator with at least three reminders by email and
phone to non-responders. We informed each country at
the time of contacting them that we would not publish
their individual results, but these would be available to
PAHO. PAHO/WHO focal points were our primary
source, but we augmented it by an internet search for
national policy and clinical guidelines on IPV/SV for
each LAC country, contact by one of the investigators
with knowledgeable colleagues where available for any
LAC country and searching the United Nations (UN)
Women website for any documented LAC national pol-
icy on IPV/SV.
The WHO Clinical and Policy Guidelines were used to
develop a scoring matrix for each country. The headings
with appropriate subheadings included women-centered
care for IPV/SV survivors, additional issues for SV survi-
vors, and training of healthcare providers. The scoring
matrix was reviewed and approved by five experts on
IPV/SV/CM (child maltreatment), including three in-
volved in developing the WHO Guidelines.
Each country’s policy and clinical guideline (where
available) was reviewed and entered into the scoring
matrix by the study coordinator along with the appropri-
ate page number. Two investigators reviewed and ap-
proved the scoring matrix entries. The scoring matrix
for each country was returned to the appropriate
PAHO/WHO focal point who was asked to review and
approve it (or provide a correction) in collaboration with
their Ministry of Health. Two reminder emails were sent
to non-responders. To preserve confidentiality of indi-
vidual PAHO/WHO countries, a total score for each
heading and subheading was developed by adding posi-
tive responses from all responding countries to identify
LAC regional strengths and gaps requiring action. We de-
fined large gaps as aggregate scores of 3 or less (out of 12),
moderate gaps as aggregate scores of 4 to 7 and strengths
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as aggregate scores of 8 to 12. An overall report was written
and submitted to PAHO/WHO.
Results
We obtained 15 national policies and 12 national clin-
ical guidelines (protocols) from a total of 18 countries
(“response” rate of 66.7 %, but not all countries had
both a policy and guideline). Countries that responded in-
cluded Argentina, Belize, Bolivia, Brazil, Chile, Colombia,
Costa Rica, Ecuador, El Salvador, Guatemala, Guyana,
Honduras, Mexico, Nicaragua, Panama, Peru, Uruguay,
Venezuela. Seven countries were “non-responders” despite
at least three reminders by email or phone and an internet
search, and two countries sent information other than na-
tional policies or guidelines. Access to policies and guide-
lines was available to the public via an online version or
the country’s Ministry of Health or Women’s Institute in
all but 2 responding countries. The definitions of IPV, SV,
CM by country varied slightly in wording, but all were
consistent with those found in the WHO Guidelines. A
few countries used the generic terms “domestic violence”
or “family violence”, but the subsequent wording clarified
the specific form of violence (IPV, SV or CM) being
discussed.
National policies
The time frame for the implementation of the 15 policies
obtained ranged from 2006 to 2017 and all addressed phys-
ical, emotional and sexual violence against women. These
were developed by the Ministry of Health (5), in collabor-
ation with one or more other government sources (9), local
or regional governments (1), professional associations (2),
or other sources (7). Policies addressed sectors in
health (15), education (13), justice or police (12), social
development (4), media (3), work (3), human rights (1),
public security (1), parliament (1) and sports (1). Most
policies addressed violence prevention (14), how to respond
to disclosure (15), in children and adolescents (14) and
women survivors (15). Two countries recommended pre-
qualification training and 12 in-service training for health
care providers, however the frequency and length of train-
ing in all policies was unspecified. The content of training
included when and how to respond to violence (3), best
ways to respond (8), how to collect forensic evidence (2),
specific information about violence against women (VAW)
local laws (7), existing services (3), provider attitudes (5),
and provider’s own experience of violence (1).
National clinical guidelines
Of the 12 national guidelines (protocols) for the health
sector that were obtained, 4 guidelines included IPV, SV
and CM, 3 covered only SV, and 5 covered one or more
of these topics, most commonly CM. Mandatory report-
ing was required for CM in 10, SV in 9 and IPV in 4
guidelines. If reporting was not mandatory, 10 guidelines
recommended respecting the women’s decision about
reporting. Ten guidelines differentiated between adult
and child survivors of SV. Recommendations in the
WHO Clinical Guidelines related to women-centered
care for IPV/SV survivors were selectively addressed in
many guidelines as shown in Table 1.
Additional recommendations for SV survivors such as
specific services, risk and management of pregnancy,
sexually transmitted infections (STIs), human immuno-
deficiency virus (HIV), hepatitis B and forensic docu-
mentation are shown in Table 2.
Table 1 Women-centered care for IPV/SV survivors (n = 12
guidelines)
Visual and auditory privacy during consultation 12
Confidentiality when information shared 12
Non-judgemental, supportive, validating reaction to disclosure 12
Safety planning or danger assessment 10
Assess and promote children’s safety 7
Provide written material about legal, housing, economic
empowerment
8
Warn of risk to women of taking home written material 0
Special needs women: mental disorder 9
physical disability 8
pregnancy 6
Universal screening (NOT recommended by WHO) 4
Selective enquiry (recommended by WHO) 4
Referral for needed services 9
Referral pathway outlined 8
Availability of directory of existing services 3
Women’s shelter available 3
Hotlines available 3




posttraumatic stress disorder 1
Provide or mobilize social support 6
Offer coping strategies for stress 0
Undertake watchful waiting to see if early distress resolves 7
Provide psychological first aid support 6
Offer structural advocacy/empowerment 6
Mental health service available 7
Offer psychotherapy for children exposed to VAW 4
Photos of injuries if present 5
Body diagram of injuries if present 7
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Training of healthcare providers on IPV/SV and the
monitoring and evaluation of policy, guidelines and ser-
vices are shown in Table 3.
Discussion
The challenges we experienced in obtaining current na-
tional policies and clinical guidelines on IPV and SV in
LAC are illustrative of some of the difficulties of con-
ducting health and policy research in low- and middle-
income countries. We acknowledge the limitation that
one third of all countries approached did not respond.
The low response rate limited researchers’ ability to
carry out subregional comparisons. Nevertheless the
information we obtained from the 66.7 % of countries
we approached provides a useful baseline snap-shot of
the strengths and gaps to inform the implementation of
the July 2013 WHO Clinical and Policy Guidelines.
Policies:
National policies we obtained were fairly comprehen-
sive in terms of covering physical, emotional, and sexual
violence and some displayed good intersectoral collabor-
ation by involving a number of government and civil
sectors, which are vital for a strong government and
community response to IPV/SV. The policies were com-
mendably strong in addressing violence prevention and
how to respond to IPV/SV in women and children in a
supportive manner. The greatest gap was in the training
of health-care providers in virtually all aspects of care
for IPV/SV survivors essential for an adequate response.
Clinical Guidelines:
Women-centered care for IPV/SV survivors was espe-
cially strong in the important areas of privacy, confidenti-
ality, danger assessment, safety planning, and supportive
reactions to disclosure. Strength was also evident in pro-
viding written information and referring to legal, housing
and economic empowerment services by a referral path-
way. Women with special needs related to mental disor-
ders and/or physical disability and referrals and referral
pathways for services were also fairly well addressed.
Moderate gaps were evident in selective enquiry for
IPV, SV, assessing mental health (suicide, self-harm, de-
pression, anxiety), providing mental health services,
psychological first aid, watchful waiting to see if early
distress resolves, providing or mobilizing social sup-
port, and structured advocacy and empowerment
Table 2 Additional issues for sexual violence survivors
Sexual assault services available 24/7 4
Record time since assault 8




Collect hair and fibers 5
Risk of pregnancy 8
Emergency contraception within 5 days SV 8
Levonorgestrel (1 or doses) 6
Combined estrogen/progesterone 5
Copper bearing IUD 1
Ulipristal acetate 0
Referral for abortion if legal and requested 4
Risk of STIs 8





Hepatitis B vaccine offered (without immunoglobulin) 5
Risk of HIV 8
HIV PEP appropriateness counselling 6
Shared decision making for HIV PEP 5
Does not require HIV testing before PEP 12
Start HIV PEP within 72 h 6
HIV testing and counselling at initial consultation 8
Regular follow-ups 5
2 drug regime for HIV PEP 4
3 drug regime for HIV PEP 4
Prioritize drugs with fewer side effects 1
Drugs follow national guidelines 5
Adherence counselling offered 5
Table 3 Training of healthcare providers
Prequalification training of doctors, nurses, midwives at university 0
In-service training for direct care providers 6
Where and how to enquire about violence 3
Best ways to respond to disclosure 5
How to collect forensic evidence 0
IPV/SV information 6
Local laws on IPV/SV 2
Existing services 3
Providers’ attitudes 3
Providers’experiences of violence 1
Length and frequency of training 1
Monitoring and evaluating services 2
Women survivors involved in evaluating services 0
Mechanism for intersectoral collaboration 5
Meetings promoted between sectors (legal, health, social) 4
Support for vicarious trauma to providers 2
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programs. Moderate gaps were also seen in assessing
and providing for children’s safety, providing psycho-
therapy for children exposed to IPV and meeting the
special needs of pregnant women, all of which are es-
sential issues. Documentation with a body diagram or
photo of injuries if present which may be essential for
legal proceedings was also a moderate gap. Large gaps
were evident in advising on coping strategies for stress
and assessing for substance abuse and posttraumatic
stress disorder. Large gaps were also present on advis-
ing women on the potential risks of taking home writ-
ten materials, directories of existing services, shelters
and hotlines, all of which are critical aspects of a
healthcare response to IPV/SV. Unfortunately, the
WHO guidance does not address IPV/SV in same sex
relationships and as our project was to examine base-
line adherence to the WHO Clinical and Policy Guide-
lines, we did not include this important topic in our
scoring matrix.
There were additional strengths in the care of SV sur-
vivors; most guidelines appropriately did not require STI
testing before treatment or HIV testing before post-
exposure prophylaxis (PEP), advising about recording
the time and type of assault, the need for vaginal swabs,
the risks of pregnancy, STI’s, Hepatitis B and HIV and
emergency contraception within five days of SV. Moder-
ate gaps for survivors of SV were seen in the availability
of sexual assault services available 24/7 and the need to
collect anal and oral swabs and hair and fibers to assist
in legal proceedings. Specific advice about types of emer-
gency contraception, referral for abortion where legal,
specific treatment for various STI’s, and offering hepa-
titis B vaccine were moderate gaps. HIV testing and
counselling at first consultation, HIV-PEP appropriate-
ness counselling, shared decision making, starting HIV
PEP within 72 h, 2 or 3 drugs for HIV PEP, regular
follow-ups, offering adherence counselling, and using
drugs that followed national guidelines were also moder-
ate gaps. Large gaps for SV survivors included prioritiz-
ing drugs with fewer side effects, although this decision
may have been pre-empted by national drug guidelines.
The largest gaps noted were in the area of providing
training to healthcare professionals who are often the
most trusted and consulted by victims of violence. We
asked about content, frequency and timing (in-service/
prequalification) training, but assessing quality was out-
side the scope of this effort. Evidence suggests that “one-
shot training” is not sufficient and trainings should be
repeated/ongoing but this is not what occurs in low-
and middle-income countries. The WHO Guidelines
state “training should be intensive and content-appropriate
to the context and setting. Intensive multidisciplinary train-
ing…should be offered to health care professionals where
referrals to specialist domestic violence services are
possible” (11: pp 35–36). Only half of the guidelines ad-
vised in-service training for frontline healthcare pro-
viders and provided information to them about IPV/SV
and the best ways to respond to disclosure. Large gaps
were reported on nearly all training items in the WHO
Clinical Guidelines. None of the guidelines included
training of prequalification healthcare workers or how
direct healthcare providers should collect forensic evidence,
so necessary for legal prosecution of perpetrators. Only one
guideline suggested the length and frequency of training
and there was poor psychological support for vicarious
trauma among healthcare providers caring for IPV/SV pa-
tients. Clearly training is a crucial step in implementing the
WHO Clinical and Policy Guidelines [11].
However, development of policies and guidelines is
only the first step; monitoring and evaluating services
for IPV/SV survivors are essential for implementation.
Large gaps were reported in promotion of mechanisms
and meetings for intersectoral collaboration and evalu-
ation of services. To the best of our knowledge, there
are no regional efforts to assess the implementation of
health sector policies/protocols, though there may be
some ongoing country-specific initiatives. The gap be-
tween policy, funding and implementation is key. PAHO
is currently preparing a Regional Strategy and Plan of
Action on strengthening health systems to address VAW
to be reviewed and (hopefully) approved by Ministers of
Health from 35 countries in the Americas. This docu-
ment highlights the gap between policy and implementa-
tion and tries to push for advancements in terms of the
creation of dedicated budget lines for VAW work within
health budgets, for instance. Optimal evaluation should
include intersectoral collaboration as well as input from
women survivors of IPV/SV. Intersectoral collaboration
is essential to improve policies and services, but also to
change the public perception against IPV/SV especially
in patriarchal societies where VAW may be tolerated or
ignored.
Conclusions
Baseline measurement of policy and clinical guidelines
for IPV/SV in LAC PAHO/WHO member countries at
the time of issuing the 2013 WHO Clinical and Policy
Guidelines reveals some important strengths, but also
serious gaps that need to be addressed. While there are
specific topic gaps within women-centered care for IPV/
SV survivors and additional issues for SV survivors, the
most pressing needs are for concerted training initiatives
for healthcare providers and strengthening multisectoral
collaboration, monitoring and evaluation of services. A
future evaluation of national policies, clinical guidelines,
monitoring and evaluation will need to be conducted to
measure the progress of the required scaling-up process.
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